APP and Alzheimer disease: In AD, the abnormal accumulation of amyloid-β (Aβ) peptides derived from enhanced β- and γ-secretase cleavage of amyloid precursor protein (APP) is believed to be a key event in initiating hallmark neurodegenerative cascades (3).